SanBio Company Limited (TYO:4592)
Japan · Delayed Price · Currency is JPY 1,854.00
-67.00 (-3.49%)
At close: Feb 6, 2026
SanBio Company Market Cap
SanBio Company has a market cap or net worth of 144.67 billion as of February 6, 2026. Its market cap has increased by 169.81% in one year.
Market Cap
144.67B
Enterprise Value
144.06B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,854.00
Market Cap Chart
Since April 8, 2015, SanBio Company's market cap has increased from 77.34B to 144.67B, an increase of 87.06%. That is a compound annual growth rate of 5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 144.67B | 9.70% |
| Dec 30, 2025 | 131.88B | 147.58% |
| Dec 30, 2024 | 53.27B | 15.83% |
| Dec 29, 2023 | 45.99B | -5.12% |
| Dec 30, 2022 | 48.47B | -7.07% |
| Dec 30, 2021 | 52.16B | -24.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 201.57B |
| GNI Group | 142.07B |
| Takara Bio | 97.42B |
| Nxera Pharma | 75.02B |
| Cuorips | 68.55B |
| Oncolys BioPharma | 50.53B |
| Healios K.K. | 43.17B |
| RaQualia Pharma | 26.40B |